Table 6.
Functional and structural characteristics and number of injections in intraretinal fluid vs no intraretinal fluid eyes
Mean (SD) | P-value | |
---|---|---|
VA at presentation | ||
No intraretinal fluid | 0.54 (0.22) | 0.22 |
Intraretinal fluid | 0.63 (0.30) | |
VA in month 4 | ||
No intraretinal fluid | 0.36 (0.20) | 0.045 |
Intraretinal fluid | 0.62 (0.47) | |
VA in month 6 | ||
No intraretinal fluid | 0.44 (0.29) | 0.24 |
Intraretinal fluid | 0.57 (0.45) | |
CMT at presentation | ||
No intraretinal fluid | 360 (133) | 0.96 |
Intraretinal fluid | 364 (102) | |
CMT in month 4 | ||
No intraretinal fluid | 279 (78) | 0.18 |
Intraretinal fluid | 250 (55) | |
CMT in month 6 | ||
No intraretinal fluid | 290 (77) | 0.65 |
Intraretinal fluid | 280 (77) | |
Number of injections | ||
No intraretinal fluid | 3.94 (0.70) | 0.43 |
Intraretinal fluid | 3.73 (0.90) |
Abbreviations: VA, visual acuity; CMT, central macular thickness.